CS
LH icon

Cannell & Spears’s Labcorp LH Stock Holding History

Cannell & Spears’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42M Sell
150,037
-1,500
-1% -$394K 0.75% 37
2026
Q1 		$40.4M Sell
151,537
-7,025
-4% -$1.9M 0.79% 38
2025
Q4 		$39.8M Sell
158,562
-1,018
-0.6% -$270K 0.74% 35
2025
Q3 		$45.8M Sell
159,580
-2,938
-2% -$787K 0.86% 32
2025
Q2 		$42.7M Sell
162,518
-1,899
-1% -$462K 0.86% 31
2025
Q1 		$38.3M Sell
164,417
-38,138
-19% -$9.25M 0.82% 35
2024
Q4 		$46.4M Buy
202,555
+32,259
+19% +$7.4M 0.95% 31
2024
Q3 		$38.1M Buy
170,296
+4,961
+3% +$1.09M 0.75% 43
2024
Q2 		$33.6M Sell
165,335
-177,536
-52% -$36.1M 0.7% 46
2024
Q1 		$74.9M Buy
342,871
+337,821
+6,690% +$74.4M 1.55% 11
2023
Q4 		$1.15M Hold
5,050
– – 0.09% 90
2023
Q3 		$1.02M Sell
5,050
-828
-14% -$175K 0.09% 87
2023
Q2 		$1.22M Buy
5,878
+4,819
+455% +$935K 0.1% 82
2023
Q1 		$209K Hold
1,059
– – 0.02% 211
2022
Q4 		$214K Buy
+1,059
New +$207K 0.02% 210
2022
Q3 		– Sell
-1,059
Closed -$213K – 203
2022
Q2 		$213K Hold
1,059
– – 0.02% 194
2022
Q1 		$240K Hold
1,059
– – 0.02% 200
2021
Q4 		$286K Hold
1,059
– – 0.02% 189
2021
Q3 		$256K Sell
1,059
-71
-6% -$17.9K 0.02% 208
2021
Q2 		$268K Sell
1,130
-349
-24% -$79.5K 0.02% 208
2021
Q1 		$324K Hold
1,479
– – 0.03% 178
2020
Q4 		$259K Hold
1,479
– – 0.02% 194
2020
Q3 		$239K Sell
1,479
-4
-0.3% -$634 0.02% 194
2020
Q2 		$212K Buy
+1,483
New +$205K 0.02% 202

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cannell & Spears's LH Position: Q2 2026 in Review

Cannell & Spears reduced its Labcorp (LH) stake by 0.99% in Q2 2026, selling an estimated $394K and leaving 150,037 shares worth $42M. The position accounts for 0.75% of the portfolio, ranked #37.

Cannell & Spears first reported a position in LH in Q2 2020 and has held it in 24 quarters since. The position peaked at $74.9M in Q1 2024. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Cannell & Spears held 150,037 shares of Labcorp worth $42M as of Q2 2026.
  • Cannell & Spears sold 1,500 Labcorp shares in Q2 2026, an estimated $394K.
  • Labcorp made up 0.75% of Cannell & Spears's portfolio in Q2 2026, its #37 holding.
  • Cannell & Spears first reported a position in Labcorp in Q2 2020 and has held it in 24 quarters since.
  • Cannell & Spears's Labcorp position peaked at $74.9M in Q1 2024.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Cannell & Spears's 13F filing for Q2 2026, filed 11 Aug 2026.